The four strategies outlined include the following:

1.    Establish a unique device identification system and promote its incorporation into electronic health information
2.    Promote the development of national and international device registries for selected products
3.    Modernize adverse event reporting and analysis
4.    Develop and use new methods for evidence generation, synthesis and appraisal

The FDA will host four public meetings this month to garner public feedback.

More Articles on Orthopedic Devices:

Bioimplants Market to Reach $134B

Judge Rejects Orthofix's Settlement Over Medicare Fraud Case

DePuy Wins Patent for Spine Cage Instruments